Appendix 4
Latest Publications - Guidance and Policies
The following guidance and policies have recently been issued by organisations such as the
Department of Health, NHS England, Public Health England, Nuffield Trust, NHS Confederation, and
Health & Social Care Information Centre amongst others.
Department of Health

The new home on the web for the Department of Health is GOV.UK. www.gov.uk/dh
Departments and agencies that have moved to GOV.UK are publishing their policies according to the
outcome the government is trying to achieve
The new place for corporate and policy information from the Department of Health and the Advisory
Committee on Clinical Excellence Awards. https://www.gov.uk/government/news/the-new-home-
Winterbourne View Hospital: Department of Health review and response
This final report into the events at Winterbourne View hospital sets out a programme of action to
transform services, so that vulnerable people no longer live inappropriately in hospitals and are
cared for in line with best practice. The government will publish a progress report on these actions
by December 2013. https://www.gov.uk/government/publications/winterbourne-view-hospital-
 Policy - NHS Constitution for England The constitution sets out rights for patients, public and staff. It outlines NHS commitments to patients and staff, and the responsibilities that the public, patients and staff owe to one another to ensure that the NHS operates fairly and effectively. All NHS bodies and private and third sector providers supplying NHS services are required by law to take account of this constitution in their decisions and actions. https://www.gov.uk/government/publications/the-nhs-constitution-for-england  Updated Policy April 2013 - Improving care for people with dementia There are around 800,000 people with dementia in the UK, and the disease costs the economy £23 billion a year. By 2040, the number of people affected is expected to double - and the costs are likely to treble. A lot can be done to help people cope with the symptoms of dementia. But at the moment, the diagnosis rate in England is only 45% - lower than Scotland and Northern Ireland. The aim is to increase diagnosis rates so that they’re among the best in Europe by: •making sure that doctors give 65 to 74 year olds information about memory services as part of the NHS health check programme, and refer them for assessment if they need it (from April 2013) •making £1 million available for innovative NHS projects to increase diagnosis rates through the Innovation Challenge Prize for Dementia •launching a new toolkit to help GPs provide better support https://www.gov.uk/government/policies/improving-care-for-people-with-dementia  Policy - Reducing obesity and improving diet (published March 2013) Helping people make healthier choices In England, most people are overweight or obese. This includes 61.3% of adults and 30% of children aged between 2 and 15. People who are overweight have a higher risk of getting type 2 diabetes, heart disease and certain cancers. Health problems associated with being overweight or obese cost the NHS more than £5 billion every year. By 2020, the Department of Health want to see: •a downward trend in the level of excess weight in adults •a sustained downward trend in the level of excess weight in children https://www.gov.uk/government/policies/reducing-obesity-and-improving-diet  Policy - Helping people make informed choices about health and social care (published Currently NHS patients can (in most circumstances) choose their GP or the hospital they’re referred
to. And personal budgets are giving people more choice and control over their social care and
support arrangements. Introducing more choice will help people get the care and support that’s
right for them, and make services more responsive to their needs. The Department of Health want
everyone to have access to the information and advice they need to make the right choices for
them. https://www.gov.uk/government/policies/helping-people-make-informed-choices-about-
Report highlights growing need to improve end of life care for minority ethnic groups. This report
highlights that the end of life care needs of Black, Asian and minority ethnic communities are varied,
growing and despite examples of good practice, overall not adequately met. A systematic review
found that lack of knowledge about services, misunderstandings and mistrust, and a lack of cultural
sensitivity on the part of service providers are identified as some of the reasons for low uptake of
end of life care by BAME communities. https://www.gov.uk/government/news/report-highlights-
Breastfeeding stats Q4 2012/13
Six Lives progress report- The report demonstrates that more people with learning disabilities have
taken up the opportunity of an annual health check to improve their health and enable preventive
interventions to stop potential health crises. https://www.gov.uk/government/publications/six-lives-
Government response to the Confidential Inquiry into premature deaths of people with learning

Review of Liverpool Care Pathway for dying patients
NHS England
The Keogh Review
. Eleven hospitals are being placed in special measures because of major failings
the government has announced. Health Secretary Jeremy Hunt said the 11 trusts, among 14
investigated for high death rates, had problems so entrenched that tough action was needed. He
cited examples of staffing problems, poor care and weak leadership. At both a local and national
level, key findings have been collated and examined and recommendations have been made
 Putting Patients First: The NHS England Business Plan for 2013/14 – 2015/16 NHS England’s business plan for 2013/14 – 2015/16, called Putting Patients First, explains how its commitment to transparency and increasing patients’ voice are fundamental to improving patient care http://www.england.nhs.uk/pp-1314-1516/  Everyone counts: Planning for Patients 2013/14 Outlines the incentives and levers used to improve services in the first year of the new NHS, where improvement is driven by clinical commissioners. http://www.england.nhs.uk/everyonecounts/  Medicines Optimisation: Helping patients to make the most of medicines NHS England is supporting its call for health professionals and patients to work together to ensure better use of medicines. Medicines play a crucial role in maintaining health, preventing illness, managing chronic conditions and curing disease. In an era of significant economic, demographic and technological challenge it is crucial that patients get the best quality outcomes from medicines. http://www.rpharms.com/promoting-pharmacy-pdfs/helping-patients-make-the-most-of-their-medicines.pdf  'A guide for Paediatricians: Children's Epilepsy Surgery Service (CESS) Guidelines for children's epilepsy brain surgery referrals in England' Epilepsy Action, in association with NHS England, has developed new guidelines to help more
children with epilepsy benefit from surgical procedures. This has been developed for paediatricians
and will help to increase the number of children referred for epilepsy surgery. The guidelines have
been produced following the introduction of a new Children's Epilepsy Surgery Service (CESS) last
NHS England announces new technical guidance to improve patient care
The guidance for GP practices explaining how better use of anonymised patient information from
general practice will help commissioners improve the quality, efficiency, and equity of health care
services. GP practices will be contacted directly with further details and materials in June
NHS England announces new technical guidance to improve patient care
http://www.england.nhs.uk/2013/05/29/nhs-england-annou-tech-guide/ guidance has been
published for GP practices explaining how better use of anonymised patient information from
general practice will help commissioners improve the quality, efficiency, and equity of health care
services. The document explains the process of how data from general practice will be collected,
anonymised and used to improve patient care.
NHS England is committed to making more information available about how services and
professionals are performing. The aim is to drive up the quality of care in the NHS and help people
choose the treatment that suits them best.
This initiative is a central part of NHS England’s ambition to ensure every patient gets high quality
care, and to build improved services for the future.
On NHS Choices you’ll find links to information about individual consultants in a number of clinical
areas. You can look at their results for a range of operations and treatments to help you make
decisions about your care. http://www.england.nhs.uk/consu-treat-outc/
Public Health England

Public health emergency contacts https://www.gov.uk/public-health-emergency-contacts--2
Public Health England (PHE) is a Category 1 Responder (Civil Contingencies Act 2004), and provides
specialist advice and support to the emergency services and NHS.
A new website ‘Longer Lives’ developed by Public Health England, providing easy access to data on
how local areas are performing on premature deaths from the five major killers – cancer, stroke,
heart, lung and liver disease. http://longerlives.phe.org.uk/
World’s largest cancer database launched by Public Health England
This new service will deliver near real-time cancer data and contain detailed clinical information on
all 350,000 cancers diagnosed each year across the 50 million people in England. Cancer specialists
across the country will have instant access to detailed clinical data, including the way tumours
respond to different types of treatment, which will speed up work to deliver personalised cancer
medicine to patients in the future https://www.gov.uk/government/news/worlds-largest-cancer-
Updated guidance on the management and treatment of Clostridium difficile infection
Nuffield Trust
Evaluating integrated and community-based care: how do we know what works?
This Nuffield
Trust report presents key learning from evaluations of 30 community-based interventions designed
to reduce emergency hospital admissions
NHS Confederation

Putting patients at the centre of care - the experiences of some of the independent sector
organisations that have reviewed the total package of care they provide in order to ensure they
continue to meet the changing needs and demands of their patients.
Engaging with Black and Minority Ethnic communities -

Health & Social Care Information Centre
NHS Safety Thermometer
is a local improvement tool for measuring, monitoring, and analysing
patient harms and 'harm free' care.
NHS Safety Thermometer report May2012-2013 http://www.hscic.gov.uk/catalogue/PUB11011
Ambulance Services 2012/13
This bulletin contains information about the ambulance services provided by the NHS in England.
The information is collected from individual ambulance trusts and shows volume of activity and
performance levels against required standards (eg responses within 8 or 19 minutes). This includes
information on emergency and urgent calls, response times and patient destinations
New method for gathering patient feedback on individual doctors goes live. The Picker Institute has
worked with consultants at the University Hospital of South Manchester NHS Foundation Trust
(UHSM), Stockport NHS Foundation Trust, and several general practices, to develop a robust method
for gathering patient feedback. http://www.pickereurope.org/new-method-for-gathering-patient-
Care Quality Commission

CQC Hospital inspection plans
The Care Quality Commission has announced changes to the way it inspects hospitals and is
introducing the changes to 18 NHS trusts by the end of next month. The CQC will carry out a mixture
of announced and unannounced inspections of hospitals. The inspection teams will be led by the
Chief Inspector of Hospitals and include: a senior NHS clinician or executive; professional and clinical
staff; Experts by Experience; patients; carers and other experts.
NICE has published the following guidance: in Quarter 1
Ref: TA 278 Technology appraisals NICE recommends omalizumab as possible additional treatment to standard asthma therapy for some people aged 6 years and over with severe persistent allergic asthma. http://publications.nice.org.uk/omalizumab-for-treating-severe-persistent-allergic-asthma-review-of-technology-appraisal-guidance-ta278 Ref: IPG 455 Interventional procedures Corneal inlay implantation for correction of Presbyopia The National Institute for Health and Care Excellence (NICE) has issued full guidance to the NHS in England, Wales, Scotland and Northern Ireland on Corneal inlay implantation for correction of Presbyopia. http://publications.nice.org.uk/corneal-inlay-implantation-for-correction-of-presbyopia-ipg455 Ref: TA 281 Terminated appraisal NICE is unable to recommend the use in the NHS of canakinumab for treating gouty arthritis attacks and reducing the frequency of subsequent attacks because no evidence submission was received from the manufacturer of the technology http://publications.nice.org.uk/canakinumab-for-treating-gouty-arthritis-attacks-and-reducing-the-frequency-of-subsequent-attacks-ta281 Ref: QS 31 Quality Standards Health and wellbeing of looked-after children and young people The health and wellbeing of looked-after children and young people – that is, their physical health, and social, educational and emotional wellbeing – is influenced by nearly all aspects of their lives and the care they receive. Experiences early in life may have long-term consequences for health and social development http://publications.nice.org.uk/quality-standard-for-the-health-and-wellbeing-of-looked-after-children-and-young-people-qs31 Ref: TA 282 Technology appraisals NICE recommends pirfenidone as a possible treatment for some people with idiopathic pulmonary fibrosis http://publications.nice.org.uk/pirfenidone-for-treating-idiopathic-pulmonary-fibrosis-ta282 Ref: IPG 454 Interventional procedures The National Institute for Health and Care Excellence (NICE) has issued full guidance to the NHS in England, Wales, Scotland and Northern Ireland on Insertion of a subcutaneous implantable cardioverter defibrillator for prevention of sudden cardiac death http://publications.nice.org.uk/insertion-of-a-subcutaneous-implantable-cardioverter-defibrillator-for-prevention-of-sudden-cardiac-ipg454 Ref: IPG 452 Interventional procedures The National Institute for Health and Care Excellence (NICE) has issued full guidance to the NHS in England, Wales, Scotland and Northern Ireland on Occipital nerve stimulation for intractable chronic migraine. http://publications.nice.org.uk/occipital-nerve-stimulation-for-intractable-chronic-migraine-ipg452 Ref: IPG 453 Interventional procedures Prostate artery embolisation for BPH involves injecting small particles into the blood vessels that supply the prostate. This blocks the blood supply, with the aim of shrinking the prostate. http://publications.nice.org.uk/prostate-artery-embolisation-for-benign-prostatic-hyperplasia-ipg453 Ref: TA 280 Technology appraisals NICE recommends abatacept taken with methotrexate as a possible treatment option for some adults with rheumatoid arthritis http://publications.nice.org.uk/abatacept-for-treating-rheumatoid-arthritis-after-the-failure-of-conventional-disease-modifying-ta280 Ref: QS 30 Quality Standards This quality standard covers the care and support of people with dementia. It applies to all social care settings and services working with and caring for people with dementia. This guidance has been incorporated into the NICE Pathways, along with other related guidance and products. http://publications.nice.org.uk/quality-standard-for-supporting-people-to-live-well-with-dementia-qs30 Ref: TA 279 Technology appraisals NICE recommends vertebroplasty and kyphoplasty (without stenting) as possible treatment options for some people with spinal compression fractures caused by osteoporosis http://publications.nice.org.uk/percutaneous-vertebroplasty-and-percutaneous-balloon-kyphoplasty-for-treating-osteoporotic-vertebral-ta279 Ref: TA 284 NICE does not recommend bevacizumab given with gemcitabine and carboplatin for treating adults with the first recurrence of platinum-sensitive advanced ovarian cancer (including fallopian tube or primary peritoneal cancer) that has not been previously treated with bevacizumab or other vascular endothelial growth factor inhibitors. - Technology appraisal: Bevacizumab in combination with paclitaxel and carboplatin for first-line treatment of advanced ovarian cancer (TA284) Guidance Ref: CG 160 Clinical guideline: Feverish illness in children (CG160) Guidance This clinical guideline updates and replaces NICE clinical guideline 47 ‘Feverish illness in children’ (published May 2007). It offers evidence-based advice on the care of young children with feverish illness. Ref: TA 283 NICE recommends ranibizumab as a possible treatment for some people who have sight problems because of macular oedema caused by retinal vein occlusion - Technology appraisal: Ranibizumab for treating visual impairment caused by macular oedema secondary to retinal vein occlusion (TA283) Guidance Ref: TA 285 NICE has advised the NHS against funding the drug bevacizumab (Avastin, manufactured by Roche) for advanced ovarian cancer[1]. In two separate pieces of final guidance published for the health service, NICE concludes that funding the treatment on the NHS does not represent the best use of taxpayers' money. http://publications.nice.org.uk/bevacizumab-in-combination-with-gemcitabine-and-carboplatin-for-treating-the-first-recurrence-of-ta285 Ref: PH 44 Physical activity: brief advice for adults in primary care http://publications.nice.org.uk/physical-activity-brief-advice-for-adults-in-primary-care-ph44 Ref: TA286 Technology appraisal: Loxapine inhalation for treating acute agitation and disturbed behaviours associated with schizophrenia and bipolar disorder (terminated appraisal) (TA286) NICE is unable to recommend the use in the NHS of loxapine inhalation for treating acute agitation and disturbed behaviours associated with schizophrenia and bipolar disorder because no evidence submission was received from the manufacturer of the technology. Ref: CG 159 Clinical guideline: Social anxiety disorder: recognition, assessment and treatment (CG159) This clinical guideline offers evidence-based advice on the recognition, assessment and treatment of social anxiety disorder in children and young people (from school age to 17 years) and adults (aged 18 years and older). It includes a recommendation on the treatment of specific phobias that updates and replaces the section of NICE technology appraisal guidance 97 that deals with phobia. Ref: QS32 Quality Standards This quality standard covers the care of women who plan for or may need a caesarean section. http://publications.nice.org.uk/quality-standard-for-caesarean-section-qs32 Ref: CG161 Clinical guidance: Falls: assessment and prevention of falls in older people (CG161) This clinical guideline extends and replaces NICE clinical guideline 21 (published November 2004). It offers evidence-based advice on preventing falls in older people. New recommendations have been added about preventing falls in older people during a hospital stay. Familial breast cancer: Classification and care of people at risk of familial breast cancer and management of breast cancer and related risks in people with a family history of breast cancer: (CG 164) http://publications.nice.org.uk/familial-breast-cancer-cg164 Pegloticase for treatment severe debilitating chronic tophaceous gout (TA 291) http://publications.nice.org.uk/pegloticase-for-treating-severe-debilitating-chronic-tophaceous-gout-ta291 Hepatitis B (chronic): Diagnosis and management of chronic hepatitis B in children, young people and adults (CG 165) http://publications.nice.org.uk/hepatitis-b-chronic-cg165 Ref: CG 163 - Clinical guidance: Idiopathic pulmonary fibrosis: the diagnosis and management of suspected idiopathic pulmonary fibrosis (CG163) This clinical guideline offers evidence-based advice on the diagnosis and management of suspected idiopathic pulmonary fibrosis in adults. Idiopathic pulmonary fibrosis is a chronic, progressive disease in which the lungs become scarred. Ruxolitinib for disease-related splenomegaly or symptoms in adults with myelofibrosis (TA289) http://publications.nice.org.uk/ruxolitinib-for-disease-related-splenomegaly-or-symptoms-in-adults-with-myelofibrosis-ta289 Mirabegron for treating symptoms of overactive bladder (TA 290) http://publications.nice.org.uk/mirabegron-for-treating-symptoms-of-overactive-bladder-ta290 Rivaroxaban for treating pulmonary embolism and preventing recurrent venous
thromboembolism (TA 287)http://publications.nice.org.uk/rivaroxaban-for-treating-

Ref: QS 33 Quality Standards
This quality standard covers the diagnosis and management of rheumatoid arthritis in adults (16
years and older). http://publications.nice.org.uk/quality-standard-for-rheumatoid-arthritis-qs33
Ref: QS 34 Quality Standards
This quality standard covers the initial management of self-harm and the provision of longer-term
support for children and young people (aged 8 years and older) and adults (aged 18 years and older)
who self-harm. http://publications.nice.org.uk/quality-standard-for-selfharm-qs34
Ref: CG 162 Clinical guidance: Stroke rehabilitation: Long-term rehabilitation after stroke (CG162)
This guideline offers evidence-based advice on the care of adults and young people aged 16 years
and older who have had a stroke with continuing impairment, activity limitation or participation
Tobacco: harm reduction approaches to smoking (PH 45) http://publications.nice.org.uk/tobacco-harm-reduction-approaches-to-smoking-ph45 Dapagliflozin in combination therapy for treating type 2 diabetes (TA 288) http://publications.nice.org.uk/dapagliflozin-in-combination-therapy-for-treating-type-2-diabetes-ta288 Ulcerative colitis: Management in adults, children and young people (CG 166) http://publications.nice.org.uk/ulcerative-colitis-cg166

Source: http://nhserewash.com/wp-content/uploads/2013/10/Item-10.2-Appendix-4-Latest-Publications.pdf

Rivendell school

Dear Parent/Guardian: Your child has been sent home today because he/she was found to have head lice. There is no need for alarm . Head lice are a common problem among school children and can happen to anyone. They are not a sign of poor health habits or poor hygiene. We provide the following information so that you can assist in controlling the condition by following the procedure to treat

Casefarmaceutiche_brevetti_e bioinvestimenti.pub

Newsletter Case farmaceutiche, tra brevetti in sca- In questo numero denza ed investimenti nelle biotecnologie - I farmaci tradizionali stanno per subire una seria minaccia dai ri- spettivi generici Aprile 2010 – A breve le case farmaceutiche tradizionali dovranno fare i conti con la sca- denza di molti brevetti riguardanti farmaci importanti. Per sopperire

Copyright © 2008-2018 All About Drugs